Navigation Links
PerkinElmer Offers Solutions for Reporter Gene Assays Screening Cost and Quality and Cell Viability in Educational Webinar
Date:8/17/2018

With increasing safety requirements, and time and financial pressure, the development of new drugs, and the execution of basic research projects, are presenting multiple challenges. To be successful in such a competitive environment, it is more important than ever to select the right approach to execute the different aspects of the multiple tasks needed to develop a new drug or to execute fundamental research.

In this webinar, which is sponsored by PerkinElmer, attendees will learn about different options for cell viability testing, the impact of such differences on the execution of R&D work, and about the possibility to run such assays on relevant cellular models.

In this Webinar, examples will be presented where different technologies have been compared to analyze the potency of transcription inhibitors, and to measure the cytotoxic potential of test compounds in relevant cellular models, using various assay and reader platforms. The relative advantages of each method will be discussed, and the key points important for the project efficiency and cost will be highlighted.

The speakers for this event will be Dr. Vincent Dupriez, Global Product Leader and European Scientific Application Leader at PerkinElmer in Brussels, Belgium; Dr. Jeanine Hinterneder, Senior Application Scientist at PerkinElmer in Hopkinton, Massachusetts, USA; and Maria Kuzikov, a Research Associate at the Fraunhofer IME Screening Port in Hamburg, Germany.

Dupriez will first make a general introduction, and will then present data generated by collaborators, about improving dual reporter gene assays quality and efficiency: use of twinlite for studying transcriptional regulation by viral inhibitor proteins, as well as selecting the best option for PBMC luminescent cell viability assays.

Kuzikov will present the data generated at the Fraunhofer IME ScreeningPort about best practices and efficient methods, space and cost-saving, to assess cell viability using the ATPlite reagent and the VICTOR Nivo™ Multimode Plate Reader and will discuss the advantages of using this platform.

Hinterneder will speak about “Improving the predictability of cytotoxicity tests by moving to 3D cell culture models.” She will illustrate the different 3D cell culture options to grow spheroids and the methods developed to analyze the viability of such spheroids.

LabRoots will host the webinar Tuesday, September 11, 2018, beginning at 10 a.m. CET. To learn more about this event, the speakers, continuing education credits offered, or to simply register for free, click here.

About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. The Company reported revenue of approximately $2.3 billion in 2015, has approximately 8,000 employees serving customers in more than 150 countries and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE or at http://www.perkinelmer.com.

About LabRoots
LabRoots is the leading scientific social networking website, which provides daily scientific trending news and science-themed apparel, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Read the full story at https://www.prweb.com/releases/perkinelmer_offers_solutions_for_reporter_gene_assays_screening_cost_and_quality_and_cell_viability_in_educational_webinar/prweb15692697.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. 2014 ACMG Foundation/Signature Genomic Labs, PerkinElmer Inc. Travel Award winner
2. North American Veterinary Heart Center Offers Dental Care to High-Risk Patients
3. IsoPlexis Collaboration Offers Breakthrough Insights into Detecting and Predicting Patient Response to T-Cell Therapy
4. IdentyTech Offers Boon Edam Products Integrated with Biometric Readers
5. iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics
6. 1U Offers Best Solution to the Username / Password Dilemma: For FREE!
7. Program offers Native American students close-up look at health care careers
8. AIBS analysis of peer review offers insights into research productivity
9. Unprecedented detail of intact neuronal receptor offers blueprint for drug developers
10. Research offers insight into cellular biology of colorectal cancer
11. Insulin offers new hope for the treatment of acute pancreatitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/11/2019)... ... ... A new report published by the Family Equality Council reveals a strong ... aged 18 to 35 already have or are considering having children, 63% in the ... all LGBTQ prospective parents, 41% are considering assisted reproductive technology (ART) such as intrauterine ...
(Date:3/9/2019)... ... ... A firm believer in causes greater than all of us, Makers Nutrition ... help fund not only research to find a cure, but services that provide hope, ... the lookout for ways to make a difference. When The Leukemia & Lymphoma Society’s ...
(Date:3/9/2019)... ... March 08, 2019 , ... Ace Laboratories, Inc. ... resveratrol + ribose hard candy lozenges ( http://www.well-mints.com ). , Well-Mints™ each contain ... hard candy base dusted with powdered sugar. , Well-Mints'™ patented technology delivers resveratrol ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... ... ... Bogey was nine years old when he injured both of his cruciate ligaments. On ... Bogey to experience problems with his mobility. According to his owners, he could barely ... the couch. , His owners, devastated at the sight of Bogey in so much pain ...
(Date:3/18/2019)... ... , ... For more than 15 years, USDM Life Sciences and ... to easily comply with FDA 21 CFR Part 11 and EMA EudraLex Volume 4 ... end-to-end GxP compliance from vendor audit through ongoing validation maintenance, including every new release. ...
(Date:3/14/2019)... ... March 14, 2019 , ... ON NOVEMBER ... Canadian partner, the Eye Machine Canada Inc., had been given approval to begin ... treating Age-Related Macular Degeneration (AMD). , The previous month, the medical devices bureau ...
(Date:3/12/2019)... ... March 12, 2019 , ... Diagenode, ... has launched its third generation long-fragment DNA shearing innovation, the Megaruptor 3. This ... user-friendly interface, automated processing, and the ability to process up to 8 ...
Breaking Biology Technology: